Cargando…

Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report

PANDAS, or pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, is a neuropsychiatric disease seen in children that presents with prevailing symptoms of obsessive-compulsive disorder (OCD), tic disorder, or both. These symptoms appear suddenly following a strepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefelfinger, Donald, Kaufman, Hannah, Gilman, Alex, Gebhart, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519259/
https://www.ncbi.nlm.nih.gov/pubmed/37753029
http://dx.doi.org/10.7759/cureus.44164
_version_ 1785109666841231360
author Hefelfinger, Donald
Kaufman, Hannah
Gilman, Alex
Gebhart, Rick
author_facet Hefelfinger, Donald
Kaufman, Hannah
Gilman, Alex
Gebhart, Rick
author_sort Hefelfinger, Donald
collection PubMed
description PANDAS, or pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, is a neuropsychiatric disease seen in children that presents with prevailing symptoms of obsessive-compulsive disorder (OCD), tic disorder, or both. These symptoms appear suddenly following a streptococcal infection, such as strep throat or scarlet fever. The antibodies formed to eradicate the streptococcal infection have been shown to alter central dopamine signaling. In spite of being acknowledged in the medical community for the last two to three decades, PANDAS is a disorder that goes unnoticed by many healthcare professionals. Unfortunately, even with correct diagnosis and utilization of commonly prescribed pharmacotherapy and psychotherapy, medical management can often be ineffective at treating the neuropsychiatric symptoms. Here, we describe a case of a 15-year-old male who presented to the primary care office with complaints of episodic behavioral changes that would occur multiple times daily. The general symptoms were centered around body dysmorphia where the patient became obsessed with fixed portions of food and became highly focused on only specific food types. The symptoms would exacerbate and progress with a dire need to burn calories, leading the patient to damage carpeted areas in the home due to regular and fanatical pacing. The patient underwent trials with serotonergic pharmacotherapy with little to no relief of the psychiatric symptoms. After discussion with his primary care physician, the patient underwent trial management with antidopaminergic therapy that resulted in significant neurological and psychiatric improvement. The use of antidopaminergic pharmacotherapy to target the induction of D1 and D2 dopamine receptors was efficacious in this patient; however, it warrants additional research with a larger sample to determine its effectiveness in the treatment of this psychiatric condition.
format Online
Article
Text
id pubmed-10519259
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-105192592023-09-26 Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report Hefelfinger, Donald Kaufman, Hannah Gilman, Alex Gebhart, Rick Cureus Family/General Practice PANDAS, or pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, is a neuropsychiatric disease seen in children that presents with prevailing symptoms of obsessive-compulsive disorder (OCD), tic disorder, or both. These symptoms appear suddenly following a streptococcal infection, such as strep throat or scarlet fever. The antibodies formed to eradicate the streptococcal infection have been shown to alter central dopamine signaling. In spite of being acknowledged in the medical community for the last two to three decades, PANDAS is a disorder that goes unnoticed by many healthcare professionals. Unfortunately, even with correct diagnosis and utilization of commonly prescribed pharmacotherapy and psychotherapy, medical management can often be ineffective at treating the neuropsychiatric symptoms. Here, we describe a case of a 15-year-old male who presented to the primary care office with complaints of episodic behavioral changes that would occur multiple times daily. The general symptoms were centered around body dysmorphia where the patient became obsessed with fixed portions of food and became highly focused on only specific food types. The symptoms would exacerbate and progress with a dire need to burn calories, leading the patient to damage carpeted areas in the home due to regular and fanatical pacing. The patient underwent trials with serotonergic pharmacotherapy with little to no relief of the psychiatric symptoms. After discussion with his primary care physician, the patient underwent trial management with antidopaminergic therapy that resulted in significant neurological and psychiatric improvement. The use of antidopaminergic pharmacotherapy to target the induction of D1 and D2 dopamine receptors was efficacious in this patient; however, it warrants additional research with a larger sample to determine its effectiveness in the treatment of this psychiatric condition. Cureus 2023-08-26 /pmc/articles/PMC10519259/ /pubmed/37753029 http://dx.doi.org/10.7759/cureus.44164 Text en Copyright © 2023, Hefelfinger et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Family/General Practice
Hefelfinger, Donald
Kaufman, Hannah
Gilman, Alex
Gebhart, Rick
Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title_full Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title_fullStr Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title_full_unstemmed Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title_short Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
title_sort efficacy of antidopaminergic pharmacotherapy in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (pandas): a case report
topic Family/General Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519259/
https://www.ncbi.nlm.nih.gov/pubmed/37753029
http://dx.doi.org/10.7759/cureus.44164
work_keys_str_mv AT hefelfingerdonald efficacyofantidopaminergicpharmacotherapyinpediatricautoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionspandasacasereport
AT kaufmanhannah efficacyofantidopaminergicpharmacotherapyinpediatricautoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionspandasacasereport
AT gilmanalex efficacyofantidopaminergicpharmacotherapyinpediatricautoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionspandasacasereport
AT gebhartrick efficacyofantidopaminergicpharmacotherapyinpediatricautoimmuneneuropsychiatricdisordersassociatedwithstreptococcalinfectionspandasacasereport